QuickView for TNRC13;jsessionid=3D765BD25ABDC6EF1EDE0A75B9F1BD6C;jsessionid=A8AB09FA390A3AE4E0D1D6F38BF237B8;jsessionid=51586F57457820B19218871CCD1B1B0A;jsessionid=7FB9896AAF1D981CF351FB86FA930E4D;jsessionid=17F673886F3B576E67C93F0E584B578D;jsessionid=FB449F36D7AF656CBCD4D662895F8CB9;jsessionid=80318F57037329C6A3745FD59299C476;jsessionid=7D66AD1E9E3E9D33C03E6E1F68C1A2C9 (gene)

1. Ataxin-2 sequesters Raptor into aggregates and impairs cellular mTORC1 signaling.
2. ATXN2 is a target of N-terminal proteolysis.
3. A Case of Coexistent Spinocerebellar Ataxia Type 2 and Primary Progressive Multiple Sclerosis-Coinci…
4. ATXN2 intermediate expansions in amyotrophic lateral sclerosis.
5. TDP-43 impairs sleep in Drosophila through Ataxin-2-dependent metabolic disturbance.

There were no clinical trials for TNRC13;jsessionid=3D765BD25ABDC6EF1EDE0A75B9F1BD6C;jsessionid=A8AB09FA390A3AE4E0D1D6F38BF237B8;jsessionid=51586F57457820B19218871CCD1B1B0A;jsessionid=7FB9896AAF1D981CF351FB86FA930E4D;jsessionid=17F673886F3B576E67C93F0E584B578D;jsessionid=FB449F36D7AF656CBCD4D662895F8CB9;jsessionid=80318F57037329C6A3745FD59299C476;jsessionid=7D66AD1E9E3E9D33C03E6E1F68C1A2C9